Literature DB >> 11381502

Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India.

N M Gupta1, R Jindal, O Prakash, R Gupta, D K Bhasin.   

Abstract

This retrospective review aimed to assess the clinical profile and outcome of squamous cell carcinoma as compared with adenocarcinoma of the lower third of esophagus and cardia following a transhiatal esophagectomy. A total of 169 patients were analyzed retrospectively in this series from 1989 to 1994. There were 100 patients with squamous cell carcinoma (SCC) and 69 patients with adenocarcinoma (ADC). All tumors were assessed by an esophagogram, upper gastrointestinal endoscopy, and abdominal ultrasonography. The surgical procedure performed in all cases was a transhiatal esophagectomy (THE). The mean age of the patients with SCC and ADC was comparable (48 +/- 14 vs 54 +/- 12 years). Male/female ratio was 1.0:1.4 in the SCC group while in the ADC group it was 8.8:1.0. The main symptom in both the groups was grade II dysphagia (62% in SCC and 60% in ADC). The mean length of the tumor was 6.6 +/- 4.5 cm in the SCC group and 4.2 +/- 3.3 cm in the ADC group. The resectability rate of the SCC group was significantly higher (76%) than in the ADC group (55%). The 6-month and 1-year survival for the SCC patients was not significantly different from the ADC patients (83.7% and 49.3% vs 85.0% and 54.0%). The 5-year survival achieved in SCC was higher than in the ADC group (11.6% vs 7.2%) but the difference was not statistically significant. Adenocarcinoma arising from the distal esophagus and cardia was more common in males, and also occurred in a higher age group and had a lower resectability rate than squamous cell carcinoma. No case of Barrett's esophagus was encountered. The short- and long-term survival in both tumors were similar.

Entities:  

Mesh:

Year:  2001        PMID: 11381502     DOI: 10.1007/s005950170129

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Chromosome 11 aneusomy in esophageal cancers and precancerous lesions--an early event in neoplastic transformation: an interphase fluorescence in situ hybridization study from south India.

Authors:  Vasavi Mohan; Shivani Ponnala; Hemakumar M Reddy; Radha Sistla; Rachel A Jesudasan; Yog Raj Ahuja; Qurratulain Hasan
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

Review 2.  Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging.

Authors:  Jennifer Q Zhang; Craig M Hooker; Malcolm V Brock; James Shin; Sue Lee; Remealle How; Noreli Franco; Helen Prevas; Alicia Hulbert; Stephen C Yang
Journal:  Ann Thorac Surg       Date:  2012-02       Impact factor: 4.330

3.  Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.

Authors:  Mimi C Tan; Nabil Mansour; Donna L White; Amy Sisson; Hashem B El-Serag; Aaron P Thrift
Journal:  Aliment Pharmacol Ther       Date:  2020-05-26       Impact factor: 8.171

4.  Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis.

Authors:  Kumar Anupam; Chatopadhyay Tusharkant; Siddhartha Datta Gupta; Ralhan Ranju
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

5.  Long Term Outcome in Patients with Esophageal Stenting for Cancer Esophagus - Our Experience at a Rural Hospital of Punjab, India.

Authors:  Parvinder Singh; Abhitesh Singh; Anantbir Singh; Ghansham Sharma; Parmod Kumar Bhatia; Amarjeet Singh Grover
Journal:  J Clin Diagn Res       Date:  2016-12-01

6.  Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.

Authors:  Tasneem Kausar; Rinu Sharma; Md Raghibul Hasan; Anoop Saraya; Tushar K Chattopadhyay; Siddartha Datta Gupta; Ranju Ralhan
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

7.  Esophageal adenocarcinoma versus squamous cell carcinoma: retrospective hospital-based analysis of a 12-year temporal trend.

Authors:  Rohan Bhome; Devendra Desai; Philip Abraham; Anand Joshi; Tarun Gupta; Anita Bhaduri; Asha Kapadia; Krishna Patel; Rahul Bhome
Journal:  Indian J Gastroenterol       Date:  2012-09-16

8.  Management of oesophageal cancer.

Authors:  Daniel K H Tong; Simon Law
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

9.  Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India.

Authors:  Dhaval Choksi; Kailash M Kolhe; Meghraj Ingle; Chetan Rathi; Harshad Khairnar; Shamshersingh G Chauhan; Vipul Chaudhary; Akash Shukla; Vikas Pandey
Journal:  J Family Med Prim Care       Date:  2020-03-26

10.  TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?

Authors:  Felipe Monge Vieira; Marcio Fernandes Chedid; Richard Ricachenevsky Gurski; Carlos Cauduro Schirmer; Leandro Totti Cavazzola; Ricardo Vitiello Schramm; André Ricardo Pereira Rosa; Cleber Dario Pinto Kruel
Journal:  Arq Bras Cir Dig       Date:  2021-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.